Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Rankning i aktier #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Aktiekurs
$3.83
Marknadsvärde
$464.45M
Förändring (1 dag)
-1.63%
Förändring (1 år)
17.17%
Land
TW
Handel Gongwin Biopharm Holdings Co., Ltd. (6617)

Kategori

Aktiekurshistorik för Gongwin Biopharm Holdings Co., Ltd. (6617)
Högsta slutkurs: $3.43 den 2026-08-01

Lägsta slutkurs: $2.71 den 2017-02-01
Aktiekurshistorik för Gongwin Biopharm Holdings Co., Ltd. från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU